Method patent issued for investigational new class of pain medication

Method patent issued for investigational new class of pain medication

Filed under: Maryland Drug Treatment Centers

The U. S. Patent and Trademark Office recently issued a patent to the U. S. Department of Health and Human Services involving resiniferatoxin, or RTX, an experimental compound that represents a potential new class of drugs to alleviate the intractable …
Read more on EurekAlert (press release)

Promoting effective self-care in college students with mental illnesses

Filed under: Maryland Drug Treatment Centers

… campuses take a risk management approach to unhealthy behaviors like drinking and drug use, and don't look at the underlying reasons why students are exhibiting such behavior,” says John Greden, M.D., executive director of the U-M Depression Center.
Read more on University of Michigan Health System News (press release)

ITL: Physician Reviews of HM-Relevant Research

Filed under: Maryland Drug Treatment Centers

… complications and mortality. by Emily Tarvin, MD, Kevin Flemmons, MD, SFHM, Laine J. Murphey MD, PhD, J. Daniel Markley, DO, Joshua Labrin, MD, Kelly C. Sponsler, MD, FHM, Section of Hospital Medicine, Vanderbilt University, Nashville, Tenn …
Read more on The Hospitalist Online